<DOC>
	<DOCNO>NCT00394823</DOCNO>
	<brief_summary>The purpose study assess impact supportive measure drug adherence patient essential hypertension</brief_summary>
	<brief_title>VALIDATE Valsartan Supportive Measures - Impact Drug Adherence Treated Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Male female patient &gt; = 18 year Females must either postmenopausal one year , surgically sterile use effective contraceptive method ( e.g . barrier method spermicide , intrauterine device , hormonal contraceptive ) . Patients mild essential hypertension : Systolic blood pressure ≥ 140 mmHg &lt; 170 and/or diastolic blood pressure ≥ 90 mmHg &lt; 105 mmHg '' Moderate severe hypertension Pregnant nursing woman A history cardiovascular disease , include angina pectoris , myocardial infarction , coronary artery bypass graft , percutaneous transluminal coronary angioplasty , transient ischemic attack , stroke , heart failure NYHA II IV Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Hypertension , valsartan , compliance</keyword>
</DOC>